Product
Supplier
Encyclopedia
Inquiry
Baricitinib buy - large image1
Baricitinib buy - image1

Baricitinib

9 Inquiries

Unit Price: Get Latest Price
CAS No.:

1187594-09-7

Grade:

Pharmaceutical Grade

Packaging:

bottle; drum

Price valid (until):

2024-08-01

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Avibactam Sodium,Blonanserin,Relebactam,Tofacitinib

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Baricitinib is a JAK1 and JAK2 inhibitor and have been used as a promising treatment for rheumatoid arthritis.

    Basic Info
    Product Name:

    Baricitinib

    Other Name:

    3-Azetidineacetonitrile,1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-;1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile;LY 3009104;Baricitinib;INCB 028050;INCB 28050;Olumiant;2-(3-(4-(3H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile;1231199-29-3;1374987-77-5

    CAS No.:

    1187594-09-7

    Molecular Formula:

    C16H17N7O2S

    InChIKeys:

    InChIKey=XUZMWHLSFXCVMG-UHFFFAOYSA-N

    Molecular Weight:

    371.41688

    Exact Mass:

    371.42

    EC Number:

    1592732-453-0

    HScode:

    29350090

    Characteristics
    PSA:

    129

    XLogP3:

    -0.5

    Density:

    1.56

    Boiling Point:

    707.2

    Flash Point:

    381.5±35.7 °C

    Refractive Index:

    1.763

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Oral

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H302 Harmful if swallowed

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P301+P317 IF SWALLOWED: Get medical help.

    P330 Rinse mouth.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Avibactam Sodium,Blonanserin,Relebactam,Tofacitinib

    Location:

    2F Building 10, Zhuhai International Health Port, 628 Airport West Road, Sanzao Town, Jinwan District, Zhuhai, Guangdong, China 519090

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    14

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    101-200

    Year of Establishment:

    2012

    Certifications:

    CERTIFICATE OF REGISTRATION

    NewRoute Pharmaceutical Technology Co., Ltd

    NewRoute Pharma  located in Zhuhai, Guangdon Province, is an innovation-oriented enterprise who engages in R&D, production and sales of API, intermediates, formulations and impurity standards.

    Since its establishment in 2012 , the company has maintained a leading momentum in the field of new drug development . Specialized in new drug technology development and achievement transfer , our company is capable of providing other enterprises with various new drug R&D , production and supporting services , which is the reason for many pharmaceutical enterprises to establish strategic cooperation with us .

  • Inquiry History
    9 Inquiries
    Country Product Purchase Quantity Date Posted
    Poland

    Baricitinib

    500 MG Apr 28, 2026
    Bangladesh

    Baricitinib

    1000 KG May 6, 2024
    Pakistan

    Baricitinib

    1 KG Jun 4, 2025
    Thailand

    baricitinib

    10 G Sep 27, 2023
    India

    Baricitinib

    50 G Oct 17, 2025
    India

    Baricitinib

    25.00 G Oct 14, 2025
    Bulgaria

    Baricitinib

    1 G Aug 18, 2025
    South Korea

    Baricitinib

    100 G Mar 27, 2025
    Bangladesh

    Butyl Acetate

    1.00 KG Nov 11, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.